Background: Current practice advocates anticoagulation therapy in patients who develop atrial fibrillation (AF) during acute myocardial infarction (AMI). However, while the poorer prognosis of these patients was documented, a prognostic distinction between “early” and “late” AF onset has not been conducted. It is possible that a different AF pathogenesis of the two may be associated with a different prognosis.Purpose: To evaluate the clinical outcomes of “early” vs. “late” AF during AMI.
|Original language||English GB|
|Journal||European Heart Journal|
|State||Published - 1 Aug 2018|